Mohammad Hossein Pourhanifeh
Overview
Explore the profile of Mohammad Hossein Pourhanifeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fazlollahpour-Naghibi A, Taha S, Shariatzadeh M, Daneshdoust D, Bagheri K, Farkhondeh T, et al.
Curr Cancer Drug Targets
. 2025 Feb;
PMID: 40017243
Cutaneous melanoma, one of the most fatal and aggressive types of skin cancer, is a malignant tumor created from pigment-producing cells called melanocytes. The mor-bidity and incidence rate of melanoma...
2.
Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S, et al.
Epigenetics Chromatin
. 2025 Jan;
18(1):3.
PMID: 39810224
Background: Colorectal cancer (CRC) remains one of the most common causes of cancer-related mortality worldwide. Its progression is influenced by complex interactions involving genetic, epigenetic, and environmental factors. Non-coding RNAs...
3.
Mobinikhaledi M, Faridzadeh A, Farkhondeh T, Pourhanifeh M, Samarghandian S
Curr Mol Med
. 2024 Sep;
24(10):1269-1281.
PMID: 39300715
Gynecological cancers are the leading cause of malignancy-related death and disability in the world. These cancers are diagnosed at end stages, and unfortunately, the standard therapeutic strategies available for the...
4.
Mozafaryan M, Rezaei P, Masoudpoor F, Bahri A, Samini M, Farkhondeh T, et al.
Curr Med Chem
. 2024 May;
PMID: 38706364
Gynecological cancers, encompassing endometrial, ovarian, and cervical cancer, pose significant challenges in clinical practice, often marked by high mortality rates and treatment resistance. Despite advances in standard therapies, including chemoradiation...
5.
Pourhanifeh M, Hosseinzadeh A, Koosha F, Reiter R, Mehrzadi S
Curr Drug Targets
. 2024 May;
25(8):543-557.
PMID: 38706348
Ferroptosis is implicated in the pathogenesis of multiple diseases, including neurodegenerative diseases, cardiovascular diseases, kidney pathologies, ischemia-reperfusion injury, and cancer. The current review article highlights the involvement of ferroptosis in...
6.
Poortalebi H, ZareDini M, Foroughi-Nematollahi S, Farkhondeh T, Samarghandian S, Pourhanifeh M
Curr Med Chem
. 2024 Feb;
31(27):4340-4361.
PMID: 38303533
Lung cancer is a leading cause of mortality and morbidity worldwide. Due to significant advances in therapeutic strategies, patients' survival and life quality have been improved, however there is still...
7.
Pourhanifeh M, Farrokhi-Kebria H, Mostanadi P, Farkhondeh T, Samarghandian S
Curr Mol Pharmacol
. 2024 Jan;
17:e18761429263063.
PMID: 38284731
Gynecological cancers are serious life-threatening diseases responsible for high morbidity and mortality around the world. Chemotherapy, radiotherapy, and surgery are considered standard therapeutic modalities for these cancers. Since the mentioned...
8.
Jamshidi-Mouselou M, Hashemi A, Jamshidi-Mouselou M, Farkhondeh T, Pourhanifeh M, Samarghandian S
Curr Med Chem
. 2024 Jan;
31(26):4180-4198.
PMID: 38265392
Quercetin, a naturally occurring polyphenolic compound found in abundance in vegetables and fruits, has emerged as a compelling subject of study in cancer treatment. This comprehensive review delves into the...
9.
Hosseinzadeh A, Pourhanifeh M, Amiri S, Sheibani M, Irilouzadian R, Reiter R, et al.
Pharmacol Rep
. 2023 Nov;
76(1):25-50.
PMID: 37995089
Fibrosis, the excessive deposition of fibrous connective tissue in an organ in response to injury, is a pathological condition affecting many individuals worldwide. Fibrosis causes the failure of tissue function...
10.
Savoji A, Kaheni Y, Rezaei P, Farkhondeh T, Pourhanifeh M, Samarghandian S
Curr Mol Med
. 2023 Nov;
24(10):1282-1290.
PMID: 37933211
Background: Urological cancers, encompassing prostate, kidney, and bladder cancers, pose significant global health challenges. Current treatment modalities, including chemotherapy, radiotherapy, and surgery, individually or in combination, have limitations in efficacy...